Newsletter May 2023 No.215
Top News
Japan is aiming to revive itself as a nation of science and technology. At the 34th Pharmaceutical Manufacturers Association of Japan (PMAJ) Policy Seminar held on March 13, 2023, experts from various fields who are leading various innovations took the stage. The seminar offered many proposals on how to revitalize the drug discovery ecosystem, including promotion of medical digital transformation (DX), utilization of rapidly developing artificial intelligence (AI), formation of bioclusters, fostering startups, and utilization of data such as personal health records (PHRs). Many proposals were made to revitalize the drug discovery ecosystem. The following is a transcript of the seminar.
Topics
- Holding of "2023 Life Science Intellectual Property Forum" -Current Status, Prospects and Challenges of Digital Therapeutics (DTx)
- The 9th Japan-Thailand Joint Symposium held
- The 6th Japan-India Symposium on Regulation of Medical Products was held.
- Held the FY2022 Meeting of Compliance Managers and Practitioners
- The 34th Pharmaceutical Consortium of Japan (PKCJ) Media Forum -Trends in Science, Technology and Innovation from a Bird's Eye View of the Life Science Field and Implications for the Drug Discovery Field- (Japanese only)
Policy Research Institute page
From JPMA
Reform of the industry itself to improve its ability to create innovations